Back to Search
Start Over
PCN137 ECONOMIC BURDEN ASSOCIATED WITH ADVERSE EVENTS AMONG PATIENTS WITH NON-METASTATIC PROSTATE CANCER TREATED WITH BICALUTAMIDE, ENZALUTAMIDE OR ABIRATERONE FOLLOWING ANDROGEN DEPRIVATION THERAPY (SURGICAL/MEDICAL CASTRATION)
- Source :
- Value in Health. 22:S82
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
- Subjects :
- Oncology
medicine.medical_specialty
Bicalutamide
business.industry
Health Policy
Public Health, Environmental and Occupational Health
medicine.disease
Androgen deprivation therapy
Prostate cancer
chemistry.chemical_compound
Abiraterone
Castration
chemistry
Internal medicine
medicine
Enzalutamide
Non metastatic
business
Adverse effect
medicine.drug
Subjects
Details
- ISSN :
- 10983015
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- Value in Health
- Accession number :
- edsair.doi...........6b7fff831c9c15d246275d7ee2a077fc